Obesity and Weight Management
Diabetes
Thyroid Diseases
Parathyroid Diseases
Dyslipidaemia (Cholesterol)
Hypertension
Osteoporosis
Adrenal Gland Diseases
Pituitary Diseases
Sleep Disorders and Hormones
Pregnancy and Endocrine Diseases
Weight-loss injections are mostly GLP-1 receptor agonists or newer dual GLP-1/GIP agonists, given daily or weekly under the skin. Originally developed for type 2 diabetes, they are also effective for obesity.
How They Work
They increase satiety and reduce hunger, slow stomach emptying and enhance glucose-dependent insulin release. Dr. Demirci studied liraglutide outcomes at the Gülhane Obesity Centre and was an investigator in the international SELECT and SOUL semaglutide trials.
Who Is Eligible?
Generally adults with a BMI of 30 kg/m² or more, or 27 kg/m² or more with a weight-related condition, who have not reached their goals with lifestyle changes alone.
Who Should Not Use Them
People with a personal or family history of medullary thyroid cancer or MEN-2, pregnant or breastfeeding women, and those needing careful assessment such as previous pancreatitis or eating disorders.
Side Effects
Nausea, vomiting, diarrhoea or constipation, usually during dose increases. Less commonly gallstones and pancreatitis. Unregulated products bought online carry serious risks — use only under medical supervision.
Frequently asked questions
Will I regain weight when I stop?
Without ongoing lifestyle measures, much of the weight may return; treatment duration and maintenance should be planned with your doctor.
Content on this website is for information only and does not replace a medical consultation.
